EcoR1 Capital’s Alpine Immune Sciences Inc ALPN Stock Holding History

EcoR1 Capital’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,000	Closed	-$39.6K	–	65
2024 Q1	$39.6K	Buy	+1,000	New	+$29.5K	﹤0.01%	59
2021 Q4	–	Sell	-7,001	Closed	-$75K	–	86
2021 Q3	$75K	Sell	7,001 -515,634	-99%	-$4.75M	﹤0.01%	71
2021 Q2	$4.7M	Sell	522,635 -218,655	-29%	-$2.38M	0.18%	43
2021 Q1	$7.86M	Hold	741,290	–	–	0.35%	35
2020 Q4	$9.34M	Hold	741,290	–	–	0.5%	30
2020 Q3	$6.52M	Buy	+741,290	New	+$6.78M	0.46%	27

EcoR1 Capital's ALPN Position: Q2 2024 in Review

EcoR1 Capital sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 1,000 shares — an estimated $39.6K sold.

EcoR1 Capital first reported a position in ALPN in Q3 2020 and held it in 6 quarters. The position peaked at $9.34M in Q4 2020. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

EcoR1 Capital reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
EcoR1 Capital sold 1,000 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $39.6K.
EcoR1 Capital first reported a position in Alpine Immune Sciences Inc in Q3 2020 and held it in 6 quarters.
EcoR1 Capital's Alpine Immune Sciences Inc position peaked at $9.34M in Q4 2020.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on EcoR1 Capital's 13F filing for Q2 2024, filed 14 Aug 2024.